Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 112216632 | 11221663 | 2 | F | 2009 | 20160915 | 20150626 | 20160924 | EXP | US-AMGEN-USASP2015062389 | AMGEN | 40.00 | YR | A | F | Y | 90.70000 | KG | 20160924 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 112216632 | 11221663 | 1 | PS | ENBREL | ETANERCEPT | 1 | Unknown | 50 MG, QWK | U | 1034018 | 103795 | 50 | MG | SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE | /wk | ||||
| 112216632 | 11221663 | 2 | SS | ENBREL | ETANERCEPT | 1 | Unknown | 50 MG, QWK | U | 103795 | 50 | MG | SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE | /wk | |||||
| 112216632 | 11221663 | 3 | C | METHOTREXATE. | METHOTREXATE | 1 | 12.5 MG, QWK | 0 | 12.5 | MG | /wk |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 112216632 | 11221663 | 1 | Rheumatoid arthritis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 112216632 | 11221663 | OT |
| 112216632 | 11221663 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 112216632 | 11221663 | Acne | |
| 112216632 | 11221663 | Decreased appetite | |
| 112216632 | 11221663 | Diarrhoea | |
| 112216632 | 11221663 | Emotional distress | |
| 112216632 | 11221663 | Erythema | |
| 112216632 | 11221663 | Female sterilisation | |
| 112216632 | 11221663 | Hypoaesthesia | |
| 112216632 | 11221663 | Injection site discomfort | |
| 112216632 | 11221663 | Injection site pain | |
| 112216632 | 11221663 | Injection site reaction | |
| 112216632 | 11221663 | Intra-uterine contraceptive device removal | |
| 112216632 | 11221663 | Mobility decreased | |
| 112216632 | 11221663 | Muscular weakness | |
| 112216632 | 11221663 | Musculoskeletal stiffness | |
| 112216632 | 11221663 | Narcolepsy | |
| 112216632 | 11221663 | Pain | |
| 112216632 | 11221663 | Rash | |
| 112216632 | 11221663 | Scar | |
| 112216632 | 11221663 | Skin disorder | |
| 112216632 | 11221663 | Stress | |
| 112216632 | 11221663 | Swelling | |
| 112216632 | 11221663 | Thermal burn | |
| 112216632 | 11221663 | Unevaluable event | |
| 112216632 | 11221663 | Weight decreased | |
| 112216632 | 11221663 | Weight fluctuation |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 112216632 | 11221663 | 1 | 20030801 | 0 |